Relative Efficacy of Repeat Course of Intravenous methyLprednisolone and Intramuscular ACTH in the Treatment of Acute Relapse of Multiple Sclerosis After Sub Response to Initial Course of Intravenous Methylprednisolone (RECLAIM): a Single Center Pilot Study
Phase of Trial: Phase II/III
Latest Information Update: 24 Mar 2016
At a glance
- Drugs Corticotropin (Primary) ; Methylprednisolone
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms RECLAIM
- 07 Jun 2017 Biomarkers information updated
- 06 Sep 2011 Planned end date changed from 1 Sep 2010 to 1 Jan 2011 as reported by ClinicalTrials.gov.
- 06 Sep 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.